Gene Expression Profiling in Anaplastic Large Cell Lymphoma and Hodgkin's Disease

References

• Benharroch, D., Meguerian-Bedoyan, Z., Lamant, L., et al. (1998) "ALK-positive lymphoma: a single disease with a broad spectrum of morphology", Blood, 91, 2076–2084.
   PubMed Web of Science ®Google Scholar
• Delsol, G., Al Saati, T., Gatter, K.C., et al. (1988) "Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleulcin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis", Am. J. Pathol., 130, 59–70.
   Web of Science ®Google Scholar
• Lamant, L., Meggetto, F., al Saati, T., et al. (1996) "High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lympho-ma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reac-tion, and P-80 immunostaining", Blood, 87, 284 — 291.
   Google Scholar
• Morris, SM., Kirstein, M.N., Valentine, M.B., et al. (1994) "Fusion of a lcinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma", Science, 263, 1281–1284.
   Google Scholar
• Delsol, G., Lamant, L., Mariame, B., et al. (1997) "A new subtype of large B-cell lymphoma expressing the ALK lcinase and lacking the 2; 5 translocation", Blood, 89, 1483–1490.
   PubMed Web of Science ®Google Scholar
• Gascoyne, R.D., Aoun, P., Wu, D., et al. (1999) "Prognostic significance of anaplastic lymphoma lcinase (ALK) protein expres-sion in adults with anaplastic large cell lymphoma", Blood, 93, 3913— 3921.
   Google Scholar
• Harris, N.L. (1999) "Hodgkin's disease: classification and differ-ential diagnosis", Mod. Pathol., 12, 159— 175.
   Web of Science ®Google Scholar
• Marafioti, T., Hummel, M., Foss, H.D., et al. (2000) "Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immu-noglobulin gene rearrangements but defective immunoglobulin transcription", Blood, 95, 1443 —1450.
   Google Scholar
• Leslie, N.T., Mauch, P.M. and Hellman, S. (1985) "Stage IA to JIB supradiaphragmatic Hodgkin's disease. Long-term survival and relapse frequency", Cancer, 55, 2072–2078.
   Google Scholar
• Diatchenko, L., Lau, Y.F., Campbell, A.P., et al. (1996) "Suppres-sion subtractive hybridization: a method for generating differen-tially regulated or tissue-specific cDNA probes and libraries". Proc. Natl. Acad. Sci. USA, 93, 6025–6030.
   Google Scholar
• Schena, M., Shalon, D., Davis, R.W., et al. (1995) "Quantitative monitoring of gene expression patterns with a complementary DNA microarray", Science, 270, 467–470.
   Google Scholar
• Mir, S.S., Richter, B.W. and Duckett, C.S. (2000) "Differential effects of CD30 activation in anaplastic large cell lymphoma and Hodgkin disease cells", Blood, 96, 4307–4312.
   PubMed Web of Science ®Google Scholar
• Wellmann, A., Thieblemont, C., Pittaluga, S., et al. (2000) "Detection of differentially expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas", Blood, 96, 398–404.
   Google Scholar
• Saffer, H., Wahed, A., Rassidakis, G.Z., et al. (2002) "Clusterin expression in malignant lymphomas: a survey of 266 cases", Mod. Pathol., 15, 1221–1226.
   Web of Science ®Google Scholar
• Lae, M.E., Ahmed, I. and Macon, W.R. (2002) "Clusterin is widely expressed in systemic anaplastic large cell lymphoma but fails to differentiate primary from secondary cutaneous anaplastic large cell lymphoma", Am. J. Clin. Pathol., 118, 773–779.
   Web of Science ®Google Scholar
• Wilson, M.R. and Easterbrook-Smith, S.B. (2000) "Clusterin is a secreted mammalian chaperone", Trends Biochem. Sci., 25, 95–98.
   Google Scholar
• Yang, C.R., Leskov, K., Hosley-Eberlein, K., et al. (2000) "Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signals cell death", Proc. Natl. Acad. Sci. USA, 97, 5907–5912.
   PubMed Web of Science ®Google Scholar
• Miyake, H., Nelson, C., Rennie, P.S., et al. (2000) "Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models", Cancer Res., 60, 2547 — 2554.
   Google Scholar
• Redondo, M., Villar, E., Torres-Munoz, J., et al. (2000) "Over-expression of clusterin in human breast carcinoma", Am. J. Pathol., 157, 393 — 399.
   Google Scholar
• Zellweger, T., Chi, K., Miyake, H., et al. (2002) "Enhanced radiation sensitivity in prostate cancer by inhibition of the cell survival protein clusterin", Clin. Cancer Res., 8, 3276— 3284.
   Web of Science ®Google Scholar
• Gaiser, T., Thorns, C., Merz, H., et al. (2002) "Gene profiling in anaplastic large-cell lymphoma-derived cell lines with cDNA expression arrays", J. Hematother. Stem. Cell Res., 11, 423–428.
   Web of Science ®Google Scholar
• Milon, L., Meyer, P., Chiadmi, M., et al. (2000) "The human nm23-H4 gene product is a mitochondrial nucleoside diphosphate lcinase", J. Biol. Chem., 275, 14264–14272.
   Web of Science ®Google Scholar
• Hayer, J., Engel, M., Seifert, M., et al. (2001) "Overexpression of nm23-H4 RNA in colorectal and renal tumours", Anticancer Res., 21, 2821–2825.
   PubMed Web of Science ®Google Scholar
• Kossakowska, A.E., Urbanski, Si. and Edwards, D.R. (1991) "Tissue inhibitor of metalloproteinases-1 (TIMP-1) RNA is expressed at elevated levels in malignant non-Hodgkin's lympho-mas", Blood, 77, 2475–2481.
   PubMed Web of Science ®Google Scholar
• Oelmann, E., Herbst, H., Zuhlsdorf, M., et al. (2002) "Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells", Blood, 99, 258 — 267.
   Google Scholar
• Hayakawa, T., Yamashita, K., Tanzawa, K., et al. (1992) "Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum", FEBS Lett., 298, 29— 32.
   Google Scholar
• Guedez, L., Courtemanch, L. and Stetler-Stevenson, M. (1998) "Tissue inhibitor of metalloproteinase (TIMP)- 1 induces differ-entiation and an antiapoptotic phenotype in germinal center B cells", Blood, 92, 1342— 1349.
   Google Scholar
• Villalva, C., Trempat, P., Greenland, C., et al. (2002) "Isolation of differentially expressed genes in NPM-ALK-positive anaplastic large cell lymphoma", Br. J. Haematol., 118, 791–798.
   Web of Science ®Google Scholar
• Rassidakis, G.Z., Sarris, A.H., Herling, M., et al. (2001) "Differ-ential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell line-age", Am. J. Pathol., 159, 527 — 535.
   Web of Science ®Google Scholar
• Rassidakis, G.Z., Jones, D., Thomaides, A., et al. (2002) "Apoptotic rate in peripheral T-cell lymphomas. A study using a tissue microarray with validation on full tissue sections", Am. J. Clin. Pathol., 118, 328 — 334.
   Web of Science ®Google Scholar
• Huang, D.C. and Strasser, A. (2000) "BH3-Only proteins-essential initiators of apoptotic cell death", Cell, 103, 839–842.
   Google Scholar
• Villalva, C., Bougrine, F., Delsol, G., et al. (2001) "Bc1-2 expression in anaplastic large cell lymphoma", Am. J. Pathol., 158, 1889— 1890.
   Web of Science ®Google Scholar
• Rassidalcis, G.Z., Jones, D., Lai, R., et al. (2003) "BCL-2 family proteins in peripheral T-cell lymphomas: correlation with tumour apoptosis and proliferation", J. Pathol., 200, 240–248.
   PubMed Web of Science ®Google Scholar
• ten Berge, R.L., Meijer, CJ., Dukers, D.F., et al. (2002) "Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma", Blood, 99, 4540–4546.
   Google Scholar
• Schlaifer, D., Krajewski, S., Galoin, S., et al. (1996) "Immunodetec-tion of apoptosis-regulating proteins in lymphomas from patients with and without human immunodeficiency virus infection", Am. J. Pathol., 149, 177 — 185.
   Web of Science ®Google Scholar
• Bai, R.Y., Ouyang, T., Miething, C., et al. (2000) "Nucleophosmin-anaplastic lymphoma lcinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-lcinase/Akt anti-apoptotic signaling pathway", Blood, 96, 4319–4327.
   PubMed Web of Science ®Google Scholar
• Amin, H.M., Medeiros, Li., Ma, Y., et al. (2003) "Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma lcinase activity in anaplastic large cell lymphoma", Oncogene, 22, 5399 — 5407.
   Google Scholar
• Epling-Burnette, P.K., Zhong, B., Bai, F., et al. (2001) "Cooperative regulation of Mcl-1 by Janus lcinase/stat and phosphatidylinositol 3-lcinase contribute to granulocyte-macrophage colony-stimulating factor-delayed apoptosis in human neutrophils", J. Immunol., 166, 7486–7495.
   PubMed Web of Science ®Google Scholar
• Khoury, J.D., Medeiros, Li., Rassidalcis, G.Z., et al. (2003) "Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK + and ALK — anaplastic large cell lymphoma", Clin. Cancer Res., 9, 3692— 3699.
   Web of Science ®Google Scholar
• Liston, P., Fong, W.G. and Korneluk, R.G. (2003) "The inhibitors of apoptosis: there is more to life than Bc12", Oncogene, 22, 8568 — 8580.
   Google Scholar
• Martelli, A.M., Tazzari, P.L., Tabellini, G., et al. (2003) "A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ioniz-ing radiation of human leukemia cells", Leukemia, 17, 1794— 1805.
   Google Scholar
• Nishihara, H., Kizaka-Kondoh, S., Insel, PA., et al. (2003) "Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)- 2", Proc. Natl. Acad. Sci. USA, 100, 8921–8926.
   PubMed Web of Science ®Google Scholar
• Uren, A.G., O'Rourke, K., Aravind, L.A., et al. (2000) "Identifica-tion of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma", MoL Cell, 6, 961 —967.
   Google Scholar
• Xu, Q. and Reed, J.C. (1998) "Bax inhibitor-1, a mammalian apoptosis suppressor identified by functional screening in yeast", MoL Cell, 1, 337–346.
   PubMed Web of Science ®Google Scholar
• Chae, Hi., Ke, N., Kim, H.R., et al. (2003) "Evolutionarily conserved cytoprotection provided by Bax Inhibitor-1 homologs from animals, plants, and yeast", Gene, 323, 101— 113.
   Google Scholar
• Grzmil, M., Thelen, P., Hemmerlein, B., et al. (2003) "Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cells", Am. J. Pathol., 163, 543–552.
   Web of Science ®Google Scholar
• Nishikori, M., Maesako, Y., Ueda, C., et al. (2003) "High-level expression of BCL3 differentiates t(2;5)(p23;q35)-positive anaplastic large cell lymphoma from Hodgkin disease", Blood, 101, 2789 — 2796.
   Google Scholar
• Rassidalcis, G.Z., Oyarzo, M.P. and Medeiros, Li. (2003) "BCL-3 overexpression in anaplastic lymphoma lcinase-positive anaplastic large cell lymphoma", Blood, 102, 1146–1147.
   PubMed Web of Science ®Google Scholar
• Seeler, J.S. and Dejean, A. (2003) "Nuclear and unclear functions of SUMO", Nat. Rev. MoL Cell. Biol., 4, 690–699.
   Google Scholar
• Desterro, J.M., Rodriguez, M.S. and Hay, R.T. (1998) "SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation", MoL Cell, 2, 233–239.
   PubMed Web of Science ®Google Scholar
• Nishimoto, T. (1999) "A new role of ran GTPase", Biochem. Biophys. Res. Commun., 262, 571 —574.
   Google Scholar
• Matunis, Mi., Wu, J. and Blobel, G. (1998) "SUMO-1 modifica-tion and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex", J. Cell. Biol., 140, 499 — 509.
   PubMed Web of Science ®Google Scholar
• Shipp, M.A., Ross, K.N., Tamayo, P., et al. (2002) "Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning", Nat. Med., 8, 68–74.
   Web of Science ®Google Scholar
• Rosenwald, A., Wright, G., Chan, W.C., et al. (2002) "The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma", N. Engl. J. Med., 346, 1937— 1947.
   Web of Science ®Google Scholar
• Schwering, I., Brauninger, A., Klein, U., et al. (2003) "Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma", Blood, 101, 1505 — 1512.
   Google Scholar
• Kuppers, R., Klein, U., Schwering, I., et al. (2003) "Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling", J. Clin. Invest., 111, 529–537.
   Google Scholar
• Devilard, E., Bertucci, F., Trempat, P., et al. (2002) "Gene expression profiling defines molecular subtypes of classical Hodg-kin's disease", Oncogene, 21, 3095–3102.
   Google Scholar
• Alizadeh, A.A., Eisen, MB., Davis, RE., et al. (2000) "Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling", Nature, 403, 503–511.
   Google Scholar
• De Vos, S., Krug, U., Hofmann, W.K., et al. (2003) "Cell cycle alterations in the blastoid variant of mantle cell lymphoma (MCL-BV) as detected by gene expression profiling of mantle cell lymphoma (MCL) and MCL-BV", Diagn. MoL Pathol., 12, 35–43.
   Google Scholar
• Welford, S.M., Gregg, J., Chen, E., et al. (1998) "Detection of differentially expressed genes in primary tumor tissues using representational differences analysis coupled to microarray hybri-dization", Nucleic Acids Res., 26, 3059 — 3065.
   Google Scholar
• Yang, G.P., Ross, D.T., Kuang, W.W., et al. (1999) "Combining SSH and cDNA microarrays for rapid identification of differentially expressed genes", Nucleic Acids Res., 27, 1517 — 1523.
   Google Scholar
• Tanaka, K., Kondoh, N., Shuda, M., et al. (2001) "Enhanced expression of mRNAs of antisecretory factor-1, gp96, DAD1 and CDC34 in human hepatocellular carcinomas", Biochim. Biophys. Acta, 1536, 1–12.
   PubMed Web of Science ®Google Scholar